Market capitalization | $171.56m |
Enterprise Value | $76.10m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 39.03 |
EV/Sales (TTM) EV/Sales | 0.65 |
P/S ratio (TTM) P/S ratio | 1.46 |
P/B ratio (TTM) P/B ratio | 0.76 |
Revenue growth (TTM) Revenue growth | -2.03% |
Revenue (TTM) Revenue | $117.45m |
As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.
5 Analysts have issued a OrganiGram Holdings Inc forecast:
5 Analysts have issued a OrganiGram Holdings Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 117 117 |
2%
2%
|
|
Gross Profit | -5.49 -5.49 |
79%
79%
|
|
EBITDA | -55 -55 |
22%
22%
|
EBIT (Operating Income) EBIT | -64 -64 |
29%
29%
|
Net Profit | -34 -34 |
82%
82%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Head office | Canada |
CEO | Beena Goldenberg |
Employees | 898 |
Founded | 2010 |
Website | www.organigram.ca |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.